You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 11, November 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (36)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Amyotrophic Lateral Sclerosis
 •Neurogenetics
 •Movement Disorders
 •Neuromuscular diseases
 •Parkinson Disease/ Parkinsonian Disorders
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

TAU as a Susceptibility Gene for Amyotropic Lateral Sclerosis–Parkinsonism Dementia Complex of Guam

Parvoneh Poorkaj, PhD; Debby Tsuang, MD; Ellen Wijsman, PhD; Ellen Steinbart, MA; Ralph M. Garruto, PhD; Ulla-Katrina Craig, PhD; Nicola H. Chapman, PhD; Leojean Anderson, BS; Thomas D. Bird, MD; Chris C. Plato, PhD; Daniel P. Perl, MD; Wigbert Weiderholt, MD; Douglas Galasko, MD; Gerard D. Schellenberg, PhD

Arch Neurol. 2001;58:1871-1878.

Background  A Guam variant of amyotrophic lateral sclerosis (ALS-G) and parkinsonism dementia complex (PDC-G) are found in the Chamorro people of Guam. Both disorders have overlapping neuropathologic findings, with neurofibrillary tangles in spinal cord and brain. The cause of ALS-G–PDC-G is unknown, although inheritance and environment appear important. Because neurofibrillary tangles containing tau protein are present in ALS-G–PDC-G, and because mutations in the tau gene (TAU) cause autosomal dominant frontotemporal dementia, TAU was examined as a candidate gene for ALS-G–PDC-G.

Methods  TAU was evaluated by DNA sequence analysis in subjects with ALS-G–PDC-G, by linkage analysis of TAU polymorphisms in an extended pedigree from the village of Umatac, and by evaluation of linkage disequilibrium with polymorphic markers flanking and within TAU.

Results  Linkage disequilibrium between ALS-G–PDC-G and the TAU polymorphism CA3662 was observed. For this 2-allele system, PDC and ALS cases were significantly less likely than Guamanian controls to have the 1 allele (4.9% and 2% vs 11.5%, respectively; Fisher exact P = .007). DNA sequence analysis of TAU coding regions did not demonstrate a mutation responsible for ALS-G–PDC-G. Analysis of TAU genotypes in an extended pedigree of subjects from Umatac showed obligate recombinants between TAU and ALS-G–PDC-G. Linkage analysis of the Umatac pedigree indicates that TAU is not the major gene for ALS-G–PDC-G.

Conclusions  The genetic association between ALS-G–PDC-G implicates TAU in the genetic susceptibility to ALS-G–PDC-G. TAU may be a modifying gene increasing risk for ALS-G–PDC-G in the presence of another, as yet, unidentified gene.


From the Geriatric Research Education Clinical Center (Drs Poorkaj, Bird, and Schellenberg and Mss Steinbart and Anderson) and Mental Illness Research Education Clinical Center (Dr Tsuang), Veterans Affairs Puget Sound Health Care System, Seattle Division, Seattle, Wash; Division of Gerontology and Geriatric Medicine (Dr Poorkaj) and Departments of Psychiatry and Behavioral Sciences (Dr Tsuang), Biostatistics (Drs Wijsman and Chapman), Medicine (Division of Medical Genetics) (Drs Wijsman and Bird), Neurology (Drs Bird and Schellenberg), and Pharmacology (Dr Schellenberg), University of Washington, Seattle; Departments of Anthropology and Biological Sciences, Binghamton University, State University of New York, Binghamton, NY (Dr Garruto); National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md (Dr Garruto); Department of Public Health, University of Guam, Mangilao (Dr Craig); Neurosciences Department, University of San Diego, San Diego, Calif (Drs Plato, Weiderholt, and Galasko); and Departments of Pathology and Psychology, Mount Sinai School of Medicine, New York, NY (Dr Perl)

Corresponding author and reprints: Gerard D. Schellenberg, PhD, GRECC 182-B, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108 (e-mail: zachdad{at}u.washington.edu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(11):1942-1944.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates
Sieh et al.
Hum Mol Genet 2009;18:3725-3738.
ABSTRACT | FULL TEXT  

The ALS/PDC syndrome of Guam and the cycad hypothesis
Steele and McGeer
Neurology 2008;70:1984-1990.
ABSTRACT | FULL TEXT  

Quantitative Proteomics Identifies Surfactant-Resistant {alpha}-Synuclein in Cerebral Cortex of Parkinsonism-Dementia Complex of Guam but Not Alzheimer's Disease or Progressive Supranuclear Palsy
Yang et al.
Am. J. Pathol. 2007;171:993-1002.
ABSTRACT | FULL TEXT  

Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam
Borenstein et al.
Neurology 2007;68:1764-1771.
ABSTRACT | FULL TEXT  

Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia
Sundar et al.
Hum Mol Genet 2007;16:295-306.
ABSTRACT | FULL TEXT  

Aluminum, Alzheimer's Disease and the Geospatial Occurrence of Similar Disorders
Perl and Moalem
Reviews in Mineralogy and Geochemistry 2006;64:115-134.
FULL TEXT  

A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders
Hermosura et al.
Proc. Natl. Acad. Sci. USA 2005;102:11510-11515.
ABSTRACT | FULL TEXT  

Genome-Wide Analysis of the Parkinsonism-Dementia Complex of Guam
Morris et al.
Arch Neurol 2004;61:1889-1897.
ABSTRACT | FULL TEXT  

A Clustering of Conjugal Amyotrophic Lateral Sclerosis in Southeastern France
Corcia et al.
Arch Neurol 2003;60:553-557.
ABSTRACT | FULL TEXT  

Genetic Modulation of Tau Phosphorylation in the Mouse
Brich et al.
J. Neurosci. 2003;23:187-192.
ABSTRACT | FULL TEXT  

Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
Forman et al.
Am. J. Pathol. 2002;160:1725-1731.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.